These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 23441126

  • 1. Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.
    Lee E, Koskimaki JE, Pandey NB, Popel AS.
    Neoplasia; 2013 Feb; 15(2):112-24. PubMed ID: 23441126
    [Abstract] [Full Text] [Related]

  • 2. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y, Katanasaka Y, Kitamura Y, Tsuda H, Nishio K, Tamura T, Koizumi F.
    Breast Cancer Res; 2011 Jun 21; 13(3):R66. PubMed ID: 21693010
    [Abstract] [Full Text] [Related]

  • 3. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M, Paupert J, Blacher S, Van de Velde M, Quesada AR, Medina MA, Noël A.
    J Hematol Oncol; 2017 Jun 19; 10(1):122. PubMed ID: 28629427
    [Abstract] [Full Text] [Related]

  • 4. Molecular control of lymphatic metastasis.
    Achen MG, Stacker SA.
    Ann N Y Acad Sci; 2008 Jun 19; 1131():225-34. PubMed ID: 18519975
    [Abstract] [Full Text] [Related]

  • 5. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y, Zhang X, Simons M.
    Arterioscler Thromb Vasc Biol; 2015 Feb 19; 35(2):421-9. PubMed ID: 25524775
    [Abstract] [Full Text] [Related]

  • 6. Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer.
    Wang J, Ma Y, Yang J, Jin L, Gao Z, Xue L, Hou L, Sui L, Liu J, Zou X.
    J Cell Mol Med; 2019 Mar 19; 23(3):2219-2229. PubMed ID: 30648805
    [Abstract] [Full Text] [Related]

  • 7. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
    Choi JU, Chung SW, Al-Hilal TA, Alam F, Park J, Mahmud F, Jeong JH, Kim SY, Byun Y.
    Biomaterials; 2017 Sep 19; 139():56-66. PubMed ID: 28586719
    [Abstract] [Full Text] [Related]

  • 8. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
    Matsui J, Funahashi Y, Uenaka T, Watanabe T, Tsuruoka A, Asada M.
    Clin Cancer Res; 2008 Sep 01; 14(17):5459-65. PubMed ID: 18765537
    [Abstract] [Full Text] [Related]

  • 9. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S.
    Int J Cancer; 2007 Nov 15; 121(10):2181-91. PubMed ID: 17597103
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E, Lee SJ, Koskimaki JE, Han Z, Pandey NB, Popel AS.
    Sci Rep; 2014 Nov 20; 4():7139. PubMed ID: 25409905
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA, Holopainen T, Wirzenius M, Keskitalo S, Jeltsch M, Ylä-Herttuala S, Wedge SR, Jürgensmeier JM, Alitalo K.
    Cancer Res; 2008 Jun 15; 68(12):4754-62. PubMed ID: 18559522
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
    Lee JY, Hong SH, Shin M, Heo HR, Jang IH.
    Biochem Biophys Res Commun; 2016 Sep 16; 478(2):733-8. PubMed ID: 27507214
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.